Frunexian
Small moleculeexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2016 (NCT02914353)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Coagulation factor XISupplementation
F11 supplementation
Chemistry & pharmacology
Loading structure…
SMILES
C[C@@H](NC(=O)N1C(=O)[C@H](Cc2ccnc(N)c2)[C@H]1C(=O)O)C1CCCCC1- Mol. weight
- 374.44 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5314583 ↗
Also known as
- ep7041
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02914353 | Phase 1 | Jul 1, 2016 | CPR Pharma Services Pty Ltd, Australia, eXIthera Pharmaceuticals, IDT Australia Ltd., INC Research |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| CPR Pharma Services Pty Ltd, Australia | For profit | 1 | 0 | 1 | 2016 |
| eXIthera Pharmaceuticals | For profit | 1 | 1 | 1 | 2016 |
| IDT Australia Ltd. | For profit | 1 | 0 | 1 | 2016 |
| INC Research | For profit | 1 | 0 | 1 | 2016 |
4 organizations
Page 1 / 1